BMP2 CCAGGTCCTTTGACCAGAG ACCATGGTCGACCTTTAGGAG
NFKB GGCATCAAACCTGAAGATTTCTC CGAACCTCAATGTCATCTTTCTG
TNF-α GCACTTTGGAGTGATCGG GAGGGTTTGCTACAACATGG
TNFR1 AACCTACTTGTACAATGACTGTCC GACCCATTTCCTTTCGGCA
TNFR2 CCAGGAACTGAAACATCAGAC CCACGTTACAGATCTGGTGG
Outline of experimental set-up concerning formation of CPP in cell culture medium containing high phosphate.
Supplemental Figure 2.
Intensity of VSMC calcification is CPP dose-dependent. A, VSMCs were cultured in growth medium supplemented with different concentrations of the secondary CPP in order to induce dose-dependent calcification (Alizarin red staining was performed after 24 hrs; Scale bar = 100 µm). B, Quantification of calcium deposition.
Supplemental Figure 3.
Supplementation of TNF-ɑ to the cell culture medium aggravated the pro-calcificatory effect of the secondary CPP towards VSMC. VSMC were treated with TNF-α (0 ng/ml, 1 ng/ml, 5 ng/ml, 10 ng/ml respectively) for 24h in the presence or absence of secondary CPP (0 µg/ml, 25 µg/ml, 50 µg/ml, 100 µg/ml). Co-transfection with TNF-ɑ siRNA and TNFR1 siRNA, enhanced the anti-calcificatory effect. VSMCs were transfected with siRNAs specific for TNF-ɑ, TNFR1 respectively, cotransfection with both siRNAs or with scrambled siRNA (siControl) as a control for 24 hrs. A, direct measurement of cell-associated calcium revealed a more pronounced suppression of calcification upon co-transfection of TNF-ɑ and TNFR1 siRNAs compared with the downregulation of the single components (mean±SD; N=3; ** p<0.01). B, cell viability assay.
